Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing

• Carlyn Rose Tan,
• Alice Wang,
• David Nemirovsky,
• Andriy Derkach,
• Tala Shekarkhand,
• Issam Hamadeh,
• Kylee Maclachlan,
• Malin Hultcrantz,
• Hani Hassoun,
• Sham Mailankody,
• Alexander Lesokhin,
• Urvi A. Shah,
• Sridevi Rajeeve,
• Hamza Hashmi,
• Dhwani Patel,
• Ross Firestone,
• Eric Jurgens,
• Kevin Miller,
• Gunjan L. Shah,
• Michael Scordo,
• Heather J. Landau,
• Sergio A. Giralt,
• Neha Korde,
• Saad Z. Usmani

Affiliations

Carlyn Rose Tan

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Correspondence: Carlyn Rose Tan, Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 530 E 74th St, New York, NY 10021;

Alice Wang

Clinical Pharmacy Services, Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY; Alice Wang, Department of Pharmacy, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021;

David Nemirovsky

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY

Andriy Derkach

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY

Tala Shekarkhand

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Issam Hamadeh

Clinical Pharmacy Services, Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY

Kylee Maclachlan

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Malin Hultcrantz

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Hani Hassoun

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Sham Mailankody

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Alexander Lesokhin

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Urvi A. Shah

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Sridevi Rajeeve

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Hamza Hashmi

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Dhwani Patel

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Ross Firestone

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Eric Jurgens

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Kevin Miller

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Gunjan L. Shah

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Michael Scordo

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Heather J. Landau

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Sergio A. Giralt

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Neha Korde

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Saad Z. Usmani

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY